| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2013 | US20130084543 Thiol-ene polymerization with vinylesters and vinylcarbonate |
| 04/04/2013 | US20130084346 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 04/04/2013 | US20130084345 Indibulin therapy |
| 04/04/2013 | US20130084341 Compositions and Methods to Promote Implantation and Engrafment of Stem Cells |
| 04/04/2013 | US20130084334 Pharmaceutical compositions highly dosed with biotin |
| 04/04/2013 | US20130084332 Taste masked pharmaceutical composition |
| 04/04/2013 | US20130084330 Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient |
| 04/04/2013 | US20130084329 Compositions for external application, containing adenosylcobalamin for improvement of skin diseases |
| 04/04/2013 | US20130084326 Liposomes for the oral delivery of therapeutic agents |
| 04/04/2013 | US20130084325 Manufacturing method of patch preparation |
| 04/04/2013 | US20130084311 Lingual Vestibular Dosage-form and Delivery System for Transmucosal Administration of Pharmaceutical Agents |
| 04/04/2013 | US20130084305 Cosmetic, external skin preparation, and medical instrument |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084281 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 04/04/2013 | US20130084280 Compositions including triciribine and methods of use thereof |
| 04/04/2013 | US20130084279 Compositions including triciribine and trastuzumab and methods of use thereof |
| 04/04/2013 | US20130084278 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 04/04/2013 | US20130084275 Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling |
| 04/04/2013 | US20130084272 Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols |
| 04/04/2013 | US20130084268 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 04/04/2013 | US20130084263 Pharmaceutical kit and method for treating cancer |
| 04/04/2013 | US20130084262 Repairing bruch's membrane with hydrogels |
| 04/04/2013 | US20130084261 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery |
| 04/04/2013 | US20130084257 Transdermal absorption promoter, and external skin formulation thereof |
| 04/04/2013 | US20130084242 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor |
| 04/04/2013 | DE10234617B4 Neues Salz von (S)-Pantoprazol New salt of (S) -pantoprazole |
| 04/04/2013 | DE102011083725A1 Estra-1,3,5(10),16-tetraen-3-carboxamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln Estra-1,3,5 (10), 16-tetraene-3-carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them, and their use for the preparation of medicaments |
| 04/04/2013 | DE102004052308B4 Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums Octenidine lozenges against inflammatory diseases of the mouth and throat |
| 04/04/2013 | CA2850610A1 Sphingosine analogs, compositions, and methods related thereto |
| 04/04/2013 | CA2850597A1 Antiviral therapies with phospholipase d inhibitors |
| 04/04/2013 | CA2850570A1 Methods of treating cancer |
| 04/04/2013 | CA2850566A1 Processes for making compounds useful as inhibitors of atr kinase |
| 04/04/2013 | CA2850564A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | CA2850551A1 Pyridine derivatives |
| 04/04/2013 | CA2850541A1 Nitrogen mustard derivatives |
| 04/04/2013 | CA2850513A1 Process for the preparation of sulfamide derivatives |
| 04/04/2013 | CA2850508A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer |
| 04/04/2013 | CA2850491A1 Treating pancreatic cancer and non-small cell lung cancer with atr inhibitors |
| 04/04/2013 | CA2850391A1 Methods of therapeutic monitoring of nitrogen scavenging drugs |
| 04/04/2013 | CA2850367A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders |
| 04/04/2013 | CA2850350A1 Macrocyclic lrrk2 kinase inhibitors |
| 04/04/2013 | CA2850346A1 Ngf aptamer and application thereof |
| 04/04/2013 | CA2850330A1 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer) |
| 04/04/2013 | CA2850258A1 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries |
| 04/04/2013 | CA2850196A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide-3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate |
| 04/04/2013 | CA2850190A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | CA2850171A1 Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia |
| 04/04/2013 | CA2850100A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | CA2850052A1 Alisporivr for treatment of hepatis c virus infection |
| 04/04/2013 | CA2850047A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments |
| 04/04/2013 | CA2850024A1 Non-aqueous patch |
| 04/04/2013 | CA2850022A1 5 - benzylaminomethyl - 6 - aminopyrazolo [3,4-b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis |
| 04/04/2013 | CA2850015A1 Improved process for the preparation of sulfamide derivatives |
| 04/04/2013 | CA2850003A1 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| 04/04/2013 | CA2849999A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | CA2849960A1 Aryl or n-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| 04/04/2013 | CA2849933A1 Substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| 04/04/2013 | CA2849910A1 Antioxidant compositions for treatment of inflammation or oxidative damage |
| 04/04/2013 | CA2849903A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | CA2849820A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | CA2849782A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | CA2849779A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin-1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
| 04/04/2013 | CA2849756A1 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 04/04/2013 | CA2849473A1 Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactives |
| 04/04/2013 | CA2849350A1 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| 04/04/2013 | CA2849000A1 Phenyl derivative |
| 04/04/2013 | CA2848518A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | CA2848154A1 Novel heterocyclic derivatives and their uses |
| 04/04/2013 | CA2848065A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | CA2847921A1 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| 04/04/2013 | CA2847860A1 Pharmaceutical compositions of n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide |
| 04/04/2013 | CA2847826A1 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 04/04/2013 | CA2846200A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | CA2845677A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) |
| 04/04/2013 | CA2845191A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/04/2013 | CA2844581A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/04/2013 | CA2818944A1 Pyrazole compounds |
| 04/04/2013 | CA2791626A1 Method for pre-debriding treatment of non-viable skin tissue and compositions and system therefor |
| 04/03/2013 | EP2574616A2 5'-substituted adenosynes, preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase. |
| 04/03/2013 | EP2574612A1 Improved process for the preparation of oxidized phospholipids |
| 04/03/2013 | EP2574610A1 Inhibitors of human immonodeficiency virus replication |
| 04/03/2013 | EP2574607A1 PDE10 modulators |
| 04/03/2013 | EP2574341A1 Effective treatment of tumors and cancer with triciribine and related compounds |
| 04/03/2013 | EP2574340A2 Combination comprising a pyrimidylaminobenzamide compound and a THR315LLEe kinase inhibitor |
| 04/03/2013 | EP2574339A1 Pharmaceutical preparation for treating NADH-related illnesses |
| 04/03/2013 | EP2574338A1 Skin preparation composition for external use with excellent antibacterial and antifungal effects |
| 04/03/2013 | EP2574337A1 Carotenoid-containing composition and production method therefor |
| 04/03/2013 | EP2574336A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/03/2013 | EP2574334A1 Bendamustine pharmaceutical compositions for lyophilisation |
| 04/03/2013 | EP2574333A1 N-acetylcysteine effervescent tablet and its therapeutical applications |
| 04/03/2013 | EP2574332A1 MC-1 R, MC-2 R, and µ opioid receptors modulation |
| 04/03/2013 | EP2574329A1 Deodorant comprising dimethyl isosorbide |
| 04/03/2013 | EP2574194A2 Macrocyclic compounds and methods of treatment |
| 04/03/2013 | EP2574172A2 Materials and methods for treatment of inflammation |
| 04/03/2013 | EP2574170A2 Immunostimulatory and vaccine compositions |
| 04/03/2013 | EP2574168A2 Topical formulation for a jak inhibitor |
| 04/03/2013 | EP2574167A2 Liquid nasal spray containing low-dose naltrexone |
| 04/03/2013 | EP2440567B1 Substituted 16,17-annellated steroid compounds for use in women's healthcare |
| 04/03/2013 | EP2421849B1 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |